Jan 16
Scrip Asks… What Does 2026 Hold For Biopharma? Part 2: Competitive Dynamics – A Landscape Reshaped
01/19/2026
Regulatory divergence across major markets is creating strategic complexity that compounds geographic competitive pressures.
Read the full article featuring Allison Cuff Shimooka from Citeline here.
Related Blog Posts
When Friction Meets Force in Clinical Research
More than a decade ago, a group of pharma R&D heads gathered for an annual meeting focused on addressing common industry challenges. They had a running joke: With an average tenure of just three years, if they wanted to see each other at more than one of these gatherings, they’d better figure out how to…
Scrip Asks… What Does 2026 Hold For Biopharma? Part 4: R&D Innovation
Enthusiastic predictions from industry leaders for ongoing progress in obesity, oncology, immunology, neuroscience and more were supported by optimism for the potential of AI and other technological advances to enable breakthroughs in processes as well as pipelines. Read the full article featuring Rob DiCicco from Citeline here.
How To Lead A Moonshot Collaboration: Lessons From Over A Decade Of Competitors Working Together
When TransCelerate launched more than a decade ago, few expected a collaboration among direct competitors to last, let alone grow into a durable, trusted organization. The numbers were seemingly against us: Most consortia struggle to survive beyond two years, typically dissolving once their founding champions retire or member companies deprioritize their involvement. Read the full…